Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare
Matinas Biopharma Holdings Inc. Revenue 2014–2023
Matinas Biopharma Holdings Inc. annual/quarterly revenue history and growth rate from 2014 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Matinas Biopharma Holdings Inc. revenue for the quarter ending March 31, 2023 was 1.1 M, a 3188.03% increase year-over-year.
- Matinas Biopharma Holdings Inc. revenue for the twelve months ending March 31, 2023 was 3.3 M, a 965.94% increase year-over-year.
- Matinas Biopharma Holdings Inc. annual revenue for 2023 was 1.1 M, a 65.62% decrease from 2022.
- Matinas Biopharma Holdings Inc. annual revenue for 2022 was 3.2 M, a 9560.61% increase from 2021.
- Matinas Biopharma Holdings Inc. annual revenue for 2021 was 33000, a 79.16% decrease from 2020.
- Matinas Biopharma Holdings Inc. annual revenue for 2020 was 158333.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Matinas Biopharma Holdings Inc. Market Cap — FAQ
Matinas Biopharma Holdings Inc. (MTNB) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MTNB's market cap history?
The chart and table above show Matinas Biopharma Holdings Inc.'s market cap by year and by quarter, including the growth rate.